Evidence map›Paper›PMID 33251214›Full record

ArticleFrontiers in cell and developmental biology2020

HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development.

Annalisa Adamo, Pietro Delfino, Alessandro Gatti, Alice Bonato, Paul Takam Kamga, Riccardo Bazzoni, Stefano Ugel, Angela Mercuri, Simone Caligola, Mauro Krampera

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Annalisa AdamoStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
Pietro DelfinoDepartment of Diagnostic and Public Health, University of Verona, Verona, Italy.
Alessandro GattiStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
Alice BonatoStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
Paul Takam KamgaStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
Riccardo BazzoniStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
Stefano UgelDepartment of Medicine, Section of Immunology, University of Verona, Verona, Italy.
Angela MercuriStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
Simone CaligolaDepartment of Medicine, Section of Immunology, University of Verona, Verona, Italy.
Mauro KramperaStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we compared the overall gene and pathway expression profiles of HS-5 and HS-27A stromal cell lines with those of primary bone marrow MSCs to verify if they can be considered a reliable alternative tool for evaluating the contribution of MSCs in tumor development and immunomodulation. Indeed, due to their easier manipulation

Indexed as

immunomodulationmesenchymal stromal cellsstromal cell linestumor biologytumor escape

Identifiers

PMID33251214
PMCPMC7674674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.